摘要
目的探讨赖脯胰岛素对肝源性糖尿病的疗效。方法选择肝源性糖尿病患者共计28例,随机分成两组,分别给予重组人胰岛素及赖脯胰岛素皮下注射,观察其治疗前后的血糖变化和低血糖的发生率。结果优泌乐组血糖控制明显好于人胰岛素组,其低血糖的发生率明显低于人胰岛素组。结论使用赖脯胰岛素对肝源性糖尿病具有较好的临床疗效。
Objective Explore lispro the effect treatment of hepatogenous diabetes. Methods Twenty-eight hepatogenous diabetes patients were assigned into 2 groups,12 patients were injected regular insulin, 16 patients were injected lispro.Observe the blood glucose change before and after the treatment and the occurrence of hypoglycemia were. Results The lispro is better than regular insulin in the control of blood glucose and has the lower occurrence in hypoglycemia. Conclusion Lispro has better clinical curative effect for the treatment ofhepatogenous diabetes patients.
出处
《糖尿病新世界》
2016年第12期20-21,共2页
Diabetes New World Magazine
关键词
优泌乐
肝源性糖尿病
低血糖
Lispro
Hepatogenous diabetes
Hypoglycemia
